Laman UtamaADVM • NASDAQ
Adverum Biotechnologies Inc
$4.27
13 Jan, 4:00:00 PG GMT-5 · USD · NASDAQ · Penafian
SahamSekuriti tersenarai ASIbu pejabat di AS
Tutup sebelumnya
$4.52
Julat hari
$4.23 - $4.51
Julat tahun
$4.23 - $29.60
Permodalan pasaran
88.83J USD
Bilangan Purata
218.97K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD)Sep 2024Perubahan T/T
Hasil
1.00J
Perbelanjaan pengendalian
9.78J-29.06%
Pendapatan bersih
-27.13J17.49%
Margin untung bersih
-2.71K
Pendapatan bagi setiap syer
-1.3060.61%
EBITDA
-28.33J14.20%
Kadar cukai berkesan
Jumlah aset
Jumlah liabiliti
(USD)Sep 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
153.24J30.88%
Jumlah aset
234.38J19.11%
Jumlah liabiliti
90.26J-4.04%
Jumlah ekuiti
144.12J
Syer tertunggak
20.80J
Harga kepada buku
0.65
Pulangan pada aset
-29.93%
Pulangan pada modal
-31.81%
Perubahan bersih dalam tunai
(USD)Sep 2024Perubahan T/T
Pendapatan bersih
-27.13J17.49%
Tunai daripada operasi
-21.12J11.66%
Tunai daripada pelaburan
-13.35J-173.34%
Tunai daripada pembiayaan
0.00100.00%
Perubahan bersih dalam tunai
-34.47J-492.17%
Aliran tunai bebas
-11.77J36.71%
Perihal
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Diasaskan
1 Jan 2006
Tapak web
Pekerja
121
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama